You are here: Industry Insights > Ortho

News List

Ortho's New COVID-19 Total and IgG Antibody Tests Receive CE Mark for Semi-Quantitative prnewswire
March 09, 2021
Ortho Clinical Diagnostics announced that its new VITROS® Anti-SARS-CoV-2 Total 2 Antibody assay and VITROS® Anti-SARS-CoV-2 IgG 2 Antibody assay received CE Mark for the qualitative and semi-quantitative detection of COVID-19 antibodies.
Ortho Clinical Diagnostics Announces Pricing of Initial Public Offering prnasia
January 28, 2021
Ortho Clinical Diagnostics Holdings plc today announced the pricing of its initial public offering of 76 million ordinary shares at $17.00 per share.
Ortho's VITROS® SARS-CoV-2 Antigen Test for Accurate, Mass-Scale COVID-19 Testing is the First High-Volume Test to Receive FDA Emergency Use Authorization prnewswire
January 13, 2021
Ortho Clinical Diagnostics, a global leader of in vitro diagnostics, announced that its VITROS® SARS-CoV-2 Antigen Test, designed to detect active infection, has become the first high-volume COVID-19 antigen test to receive ...
Ortho's VITROS® SARS-CoV-2 Antigen Test Capable of Accurate Mass-Scale Testing Achieves CE Mark prnasia
October 28, 2020
Ortho Clinical Diagnostics, a global leader of in vitro diagnostics, announced that its new VITROS® SARS-CoV-2 Antigen test, designed to detect active SARS-CoV-2 infection, achieved CE Mark for distribution throughout the EU.
Ortho's Total Antibody Test for COVID-19 Receives Emergency Use Authorization from FDA prnasia
April 15, 2020
The U.S. Food and Drug Administration (FDA) today announced it granted Emergency Use Authorization to Ortho Clinical Diagnostics' total antibody assay for COVID-19—the VITROS® Immunodiagnostic Products Anti-SARS-CoV-2 Total Reagent Pack and Calibrators.
Ortho's VITROS® XT MicroSlide receives CE Mark biospectrumasia
March 19, 2019
Ortho Clinical Diagnostics, a global leader of in vitro diagnostics, announced it has received CE Mark for Ortho’s VITROS® XT MicroSlide, a new multi-test technology that allows labs to run two tests simultaneously.
Janssen Issues Recall for ORTHO-NOVUM 1/35, ORTHO-NOVUM 7/7/7 americanpharmaceuticalreview
November 07, 2018
Janssen Issues Recall for ORTHO-NOVUM 1/35, ORTHO-NOVUM 7/7/7

Previous page 1 2 Next page